<?xml version="1.0" encoding="UTF-8"?>
<protein>
  <version>3.5</version>
  <creation_date>2013-01-15 18:52:28 -0700</creation_date>
  <update_date>2013-05-27 11:15:45 -0600</update_date>
  <accession>HMDBP00938</accession>
  <secondary_accessions>
    <accession>6226</accession>
    <accession>HMDBP05047</accession>
  </secondary_accessions>
  <protein_type>Unknown</protein_type>
  <synonyms>
    <synonym>GTP cyclohydrolase I</synonym>
    <synonym>GTP-CH-I</synonym>
  </synonyms>
  <gene_name>GCH1</gene_name>
  <general_function>Involved in GTP cyclohydrolase I activity</general_function>
  <specific_function>Positively regulates nitric oxide synthesis in umbilical vein endothelial cells (HUVECs). May be involved in dopamine synthesis. May modify pain sensitivity and persistence. Isoform GCH-1 is the functional enzyme, the potential function of the enzymatically inactive isoforms remains unknown.
</specific_function>
  <pathways>
    <pathway>
      <name>Pterine Biosynthesis</name>
      <smpdb_id>SMP00005</smpdb_id>
      <kegg_map_id>map00790</kegg_map_id>
    </pathway>
    <pathway>
      <name>7,8-dihydroneopterin triphosphate biosynthesis</name>
      <smpdb_id/>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Folate biosynthesis</name>
      <smpdb_id/>
      <kegg_map_id>map00790</kegg_map_id>
    </pathway>
  </pathways>
  <metabolite_associations>
    <metabolite>
      <accession>HMDB01273</accession>
      <name>Guanosine triphosphate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB06822</accession>
      <name>Formamidopyrimidine nucleoside triphosphate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB06821</accession>
      <name>2,5-Diaminopyrimidine nucleoside triphosphate </name>
    </metabolite>
    <metabolite>
      <accession>HMDB06823</accession>
      <name>2,5-Diamino-6-(5'-triphosphoryl-3',4'-trihydroxy-2'-oxopentyl)-amino-4-oxopyrimidine</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00980</accession>
      <name>Dihydroneopterin triphosphate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00027</accession>
      <name>Tetrahydrobiopterin</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00142</accession>
      <name>Formic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02111</accession>
      <name>Water</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00863</accession>
      <name>Isopropyl alcohol</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00132</accession>
      <name>Guanine</name>
    </metabolite>
  </metabolite_associations>
  <go_classifications>
    <go_class>
      <category>function</category>
      <description>hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>catalytic activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>hydrolase activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>cyclohydrolase activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>gtp cyclohydrolase activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>gtp cyclohydrolase i activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>metabolic process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>cellular metabolic process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>cellular aromatic compound metabolic process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>folic acid and derivative metabolic process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>folic acid and derivative biosynthetic process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>tetrahydrofolate biosynthetic process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>component</category>
      <description>cell part</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>component</category>
      <description>intracellular part</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>component</category>
      <description>cytoplasm</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>cytoplasmic vesicle</description>
      <go_id>GO:0031410</go_id>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>cytosol</description>
      <go_id>GO:0005829</go_id>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>nuclear membrane</description>
      <go_id>GO:0031965</go_id>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>protein complex</description>
      <go_id>GO:0043234</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>calcium ion binding</description>
      <go_id>GO:0005509</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>coenzyme binding</description>
      <go_id>GO:0050662</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>GTP binding</description>
      <go_id>GO:0005525</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>GTP cyclohydrolase I activity</description>
      <go_id>GO:0003934</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>zinc ion binding</description>
      <go_id>GO:0008270</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>7,8-dihydroneopterin 3'-triphosphate biosynthetic process</description>
      <go_id>GO:0035998</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>dopamine biosynthetic process</description>
      <go_id>GO:0042416</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>GTP catabolic process</description>
      <go_id>GO:0006184</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>induction of apoptosis</description>
      <go_id>GO:0006917</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>negative regulation of blood pressure</description>
      <go_id>GO:0045776</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>neuromuscular process controlling posture</description>
      <go_id>GO:0050884</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>nitric oxide biosynthetic process</description>
      <go_id>GO:0006809</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>positive regulation of nitric-oxide synthase activity</description>
      <go_id>GO:0051000</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>protein heterooligomerization</description>
      <go_id>GO:0051291</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>protein homooligomerization</description>
      <go_id>GO:0051260</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>regulation of blood pressure</description>
      <go_id>GO:0008217</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>regulation of lung blood pressure</description>
      <go_id>GO:0014916</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>response to interferon-gamma</description>
      <go_id>GO:0034341</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>response to lipopolysaccharide</description>
      <go_id>GO:0032496</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>response to pain</description>
      <go_id>GO:0048265</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>response to tumor necrosis factor</description>
      <go_id>GO:0034612</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>tetrahydrobiopterin biosynthetic process</description>
      <go_id>GO:0006729</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>tetrahydrofolate biosynthetic process</description>
      <go_id>GO:0046654</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>vasodilation</description>
      <go_id>GO:0042311</go_id>
    </go_class>
  </go_classifications>
  <subcellular_locations>
    <subcellular_location>Cytoplasm</subcellular_location>
    <subcellular_location>Nucleus</subcellular_location>
  </subcellular_locations>
  <gene_properties>
    <chromosome_location>14</chromosome_location>
    <locus>14q22.1-q22.2</locus>
    <gene_sequence>&gt;753 bp
ATGGAGAAGGGCCCTGTGCGGGCACCGGCGGAGAAGCCGCGGGGCGCCAGGTGCAGCAAT
GGGTTCCCCGAGCGGGATCCGCCGCGGCCCGGGCCCAGCAGGCCGGCGGAGAAGCCCCCG
CGGCCCGAGGCCAAGAGCGCGCAGCCCGCGGACGGCTGGAAGGGCGAGCGGCCCCGCAGC
GAGGAGGATAACGAGCTGAACCTCCCTAACCTGGCAGCCGCCTACTCGTCCATCCTGAGC
TCGCTGGGCGAGAACCCCCAGCGGCAAGGGCTGCTCAAGACGCCCTGGAGGGCGGCCTCG
GCCATGCAGTTCTTCACCAAGGGCTACCAGGAGACCATCTCAGATGTCCTAAACGATGCT
ATATTTGATGAAGATCATGATGAGATGGTGATTGTGAAGGACATAGACATGTTTTCCATG
TGTGAGCATCACTTGGTTCCATTTGTTGGAAAGGTCCATATTGGTTATCTTCCTAACAAG
CAAGTCCTTGGCCTCAGCAAACTTGCGAGGATTGTAGAAATCTATAGTAGAAGACTACAA
GTTCAGGAGCGCCTTACAAAACAAATTGCTGTAGCAATCACGGAAGCCTTGCGGCCTGCT
GGAGTCGGGGTAGTGGTTGAAGCAACACACATGTGTATGGTAATGCGAGGTGTACAGAAA
ATGAACAGCAAAACTGTGACCAGCACAATGTTGGGTGTGTTCCGGGAGGATCCAAAGACT
CGGGAAGAGTTCCTGACTCTCATTAGGAGCTGA</gene_sequence>
  </gene_properties>
  <protein_properties>
    <residue_number>250</residue_number>
    <molecular_weight>27902.855</molecular_weight>
    <theoretical_pi>8.556</theoretical_pi>
    <pfams>
      <pfam>
        <name>GTP_cyclohydroI</name>
        <pfam_id>PF01227</pfam_id>
      </pfam>
    </pfams>
    <transmembrane_regions>
    </transmembrane_regions>
    <signal_regions>
    </signal_regions>
    <protein_sequence>&gt;GTP cyclohydrolase 1
MEKGPVRAPAEKPRGARCSNGFPERDPPRPGPSRPAEKPPRPEAKSAQPADGWKGERPRS
EEDNELNLPNLAAAYSSILSSLGENPQRQGLLKTPWRAASAMQFFTKGYQETISDVLNDA
IFDEDHDEMVIVKDIDMFSMCEHHLVPFVGKVHIGYLPNKQVLGLSKLARIVEIYSRRLQ
VQERLTKQIAVAITEALRPAGVGVVVEATHMCMVMRGVQKMNSKTVTSTMLGVFREDPKT
REEFLTLIRS</protein_sequence>
  </protein_properties>
  <genbank_protein_id>19343964</genbank_protein_id>
  <uniprot_id>P30793</uniprot_id>
  <uniprot_name>GCH1_HUMAN</uniprot_name>
  <pdb_ids>
    <pdb_id>1FB1</pdb_id>
  </pdb_ids>
  <genbank_gene_id>BC025415</genbank_gene_id>
  <genecard_id>GCH1</genecard_id>
  <geneatlas_id>GCH1</geneatlas_id>
  <hgnc_id>HGNC:4193</hgnc_id>
  <general_references>
    <reference>
      <reference_text>Togari A, Ichinose H, Matsumoto S, Fujita K, Nagatsu T: Multiple mRNA forms of human GTP cyclohydrolase I.  Biochem Biophys Res Commun. 1992 Aug 31;187(1):359-65.</reference_text>
      <pubmed_id>1520321</pubmed_id>
    </reference>
    <reference>
      <reference_text>Gutlich M, Jaeger E, Rucknagel KP, Werner T, Rodl W, Ziegler I, Bacher A: Human GTP cyclohydrolase I: only one out of three cDNA isoforms gives rise to the active enzyme. Biochem J. 1994 Aug 15;302 ( Pt 1):215-21.</reference_text>
      <pubmed_id>8068008</pubmed_id>
    </reference>
    <reference>
      <reference_text>Nomura T, Ohtsuki M, Matsui S, Sumi-Ichinose C, Nomura H, Hagino Y, Iwase K, Ichinose H, Fujita K, Nagatsu T: Isolation of a full-length cDNA clone for human GTP cyclohydrolase I type 1 from pheochromocytoma. J Neural Transm Gen Sect. 1995;101(1-3):237-42.</reference_text>
      <pubmed_id>8695054</pubmed_id>
    </reference>
    <reference>
      <reference_text>Golderer G, Werner ER, Heufler C, Strohmaier W, Grobner P, Werner-Felmayer G: GTP cyclohydrolase I mRNA: novel splice variants in the slime mould Physarum polycephalum and in human monocytes (THP-1) indicate conservation of mRNA processing. Biochem J. 2001 Apr 15;355(Pt 2):499-507.</reference_text>
      <pubmed_id>11284739</pubmed_id>
    </reference>
    <reference>
      <reference_text>Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.</reference_text>
      <pubmed_id>15489334</pubmed_id>
    </reference>
    <reference>
      <reference_text>Witter K, Werner T, Blusch JH, Schneider EM, Riess O, Ziegler I, Rodl W, Bacher A, Gutlich M: Cloning, sequencing and functional studies of the gene encoding human GTP cyclohydrolase I. Gene. 1996 Jun 1;171(2):285-90.</reference_text>
      <pubmed_id>8666288</pubmed_id>
    </reference>
    <reference>
      <reference_text>Gutlich M, Schott K, Werner T, Bacher A, Ziegler I: Species and tissue specificity of mammalian GTP cyclohydrolase I messenger RNA. Biochim Biophys Acta. 1992 Dec 29;1171(2):133-40.</reference_text>
      <pubmed_id>1482676</pubmed_id>
    </reference>
    <reference>
      <reference_text>Ichinose H, Ohye T, Matsuda Y, Hori T, Blau N, Burlina A, Rouse B, Matalon R, Fujita K, Nagatsu T: Characterization of mouse and human GTP cyclohydrolase I genes. Mutations in patients with GTP cyclohydrolase I deficiency. J Biol Chem. 1995 Apr 28;270(17):10062-71.</reference_text>
      <pubmed_id>7730309</pubmed_id>
    </reference>
    <reference>
      <reference_text>Blau N, Niederwieser A: The application of 8-aminoguanosine triphosphate, a new inhibitor of GTP cyclohydrolase I, to the purification of the enzyme from human liver. Biochim Biophys Acta. 1986 Jan 15;880(1):26-31.</reference_text>
      <pubmed_id>3753653</pubmed_id>
    </reference>
    <reference>
      <reference_text>Shen RS, Alam A, Zhang YX: Human liver GTP cyclohydrolase I: purification and some properties.  Biochimie. 1989 Mar;71(3):343-9.</reference_text>
      <pubmed_id>2500984</pubmed_id>
    </reference>
    <reference>
      <reference_text>Schoedon G, Redweik U, Curtius HC: Purification of GTP cyclohydrolase I from human liver and production of specific monoclonal antibodies. Eur J Biochem. 1989 Jan 2;178(3):627-34.</reference_text>
      <pubmed_id>2463916</pubmed_id>
    </reference>
    <reference>
      <reference_text>Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Schmidt K, Weiss G, Wachter H: Pteridine biosynthesis in human endothelial cells. Impact on nitric oxide-mediated formation of cyclic GMP. J Biol Chem. 1993 Jan 25;268(3):1842-6.</reference_text>
      <pubmed_id>7678411</pubmed_id>
    </reference>
    <reference>
      <reference_text>Thony B, Blau N: Mutations in the GTP cyclohydrolase I and 6-pyruvoyl-tetrahydropterin synthase genes. Hum Mutat. 1997;10(1):11-20.</reference_text>
      <pubmed_id>9222755</pubmed_id>
    </reference>
    <reference>
      <reference_text>Katusic ZS, Stelter A, Milstien S: Cytokines stimulate GTP cyclohydrolase I gene expression in cultured human umbilical vein endothelial cells. Arterioscler Thromb Vasc Biol. 1998 Jan;18(1):27-32.</reference_text>
      <pubmed_id>9445252</pubmed_id>
    </reference>
    <reference>
      <reference_text>Cai S, Alp NJ, McDonald D, Smith I, Kay J, Canevari L, Heales S, Channon KM: GTP cyclohydrolase I gene transfer augments intracellular tetrahydrobiopterin in human endothelial cells: effects on nitric oxide synthase activity, protein levels and dimerisation. Cardiovasc Res. 2002 Sep;55(4):838-49.</reference_text>
      <pubmed_id>12176133</pubmed_id>
    </reference>
    <reference>
      <reference_text>Ohtsuki M, Shiraishi H, Kato T, Kuroda R, Tazawa M, Sumi-Ichinose C, Tada S, Udagawa Y, Itoh M, Hishida H, Ichinose H, Nagatsu T, Hagino Y, Nomura T: cAMP inhibits cytokine-induced biosynthesis of tetrahydrobiopterin in human umbilical vein endothelial cells. Life Sci. 2002 Mar 22;70(18):2187-98.</reference_text>
      <pubmed_id>12002810</pubmed_id>
    </reference>
    <reference>
      <reference_text>Gesierich A, Niroomand F, Tiefenbacher CP: Role of human GTP cyclohydrolase I and its regulatory protein in tetrahydrobiopterin metabolism. Basic Res Cardiol. 2003 Mar;98(2):69-75.</reference_text>
      <pubmed_id>12607127</pubmed_id>
    </reference>
    <reference>
      <reference_text>Shiraishi H, Kato T, Atsuta K, Sumi-Ichinose C, Ohtsuki M, Itoh M, Hishida H, Tada S, Udagawa Y, Nagatsu T, Hagino Y, Ichinose H, Nomura T: cGMP inhibits GTP cyclohydrolase I activity and biosynthesis of tetrahydrobiopterin in human umbilical vein endothelial cells. J Pharmacol Sci. 2003 Nov;93(3):265-71.</reference_text>
      <pubmed_id>14646243</pubmed_id>
    </reference>
    <reference>
      <reference_text>Suzuki T, Kurita H, Ichinose H: GTP cyclohydrolase I utilizes metal-free GTP as its substrate.  Eur J Biochem. 2004 Jan;271(2):349-55.</reference_text>
      <pubmed_id>14717702</pubmed_id>
    </reference>
    <reference>
      <reference_text>Duan CL, Su Y, Zhao CL, Lu LL, Xu QY, Yang H: The assays of activities and function of TH, AADC, and GCH1 and their potential use in ex vivo gene therapy of PD. Brain Res Brain Res Protoc. 2005 Dec;16(1-3):37-43.</reference_text>
      <pubmed_id>16338639</pubmed_id>
    </reference>
    <reference>
      <reference_text>Huang A, Zhang YY, Chen K, Hatakeyama K, Keaney JF Jr: Cytokine-stimulated GTP cyclohydrolase I expression in endothelial cells requires coordinated activation of nuclear factor-kappaB and Stat1/Stat3. Circ Res. 2005 Feb 4;96(2):164-71. Epub 2004 Dec 16.</reference_text>
      <pubmed_id>15604419</pubmed_id>
    </reference>
    <reference>
      <reference_text>Kalivendi S, Hatakeyama K, Whitsett J, Konorev E, Kalyanaraman B, Vasquez-Vivar J: Changes in tetrahydrobiopterin levels in endothelial cells and adult cardiomyocytes induced by LPS and hydrogen peroxide--a role for GFRP? Free Radic Biol Med. 2005 Feb 15;38(4):481-91.</reference_text>
      <pubmed_id>15649650</pubmed_id>
    </reference>
    <reference>
      <reference_text>Pandya MJ, Golderer G, Werner ER, Werner-Felmayer G: Interaction of human GTP cyclohydrolase I with its splice variants.  Biochem J. 2006 Nov 15;400(1):75-80.</reference_text>
      <pubmed_id>16848765</pubmed_id>
    </reference>
    <reference>
      <reference_text>Chavan B, Gillbro JM, Rokos H, Schallreuter KU: GTP cyclohydrolase feedback regulatory protein controls cofactor 6-tetrahydrobiopterin synthesis in the cytosol and in the nucleus of epidermal keratinocytes and melanocytes. J Invest Dermatol. 2006 Nov;126(11):2481-9. Epub 2006 Jun 15.</reference_text>
      <pubmed_id>16778797</pubmed_id>
    </reference>
    <reference>
      <reference_text>Swick L, Kapatos G: A yeast 2-hybrid analysis of human GTP cyclohydrolase I protein interactions. J Neurochem. 2006 Jun;97(5):1447-55.</reference_text>
      <pubmed_id>16696853</pubmed_id>
    </reference>
    <reference>
      <reference_text>Tegeder I, Costigan M, Griffin RS, Abele A, Belfer I, Schmidt H, Ehnert C, Nejim J, Marian C, Scholz J, Wu T, Allchorne A, Diatchenko L, Binshtok AM, Goldman D, Adolph J, Sama S, Atlas SJ, Carlezon WA, Parsegian A, Lotsch J, Fillingim RB, Maixner W, Geisslinger G, Max MB, Woolf CJ: GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med. 2006 Nov;12(11):1269-77. Epub 2006 Oct 22.</reference_text>
      <pubmed_id>17057711</pubmed_id>
    </reference>
    <reference>
      <reference_text>Widder JD, Chen W, Li L, Dikalov S, Thony B, Hatakeyama K, Harrison DG: Regulation of tetrahydrobiopterin biosynthesis by shear stress.  Circ Res. 2007 Oct 12;101(8):830-8. Epub 2007 Aug 17.</reference_text>
      <pubmed_id>17704208</pubmed_id>
    </reference>
    <reference>
      <reference_text>Mayya V, Lundgren DH, Hwang SI, Rezaul K, Wu L, Eng JK, Rodionov V, Han DK: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal. 2009 Aug 18;2(84):ra46.</reference_text>
      <pubmed_id>19690332</pubmed_id>
    </reference>
    <reference>
      <reference_text>Auerbach G, Herrmann A, Bracher A, Bader G, Gutlich M, Fischer M, Neukamm M, Garrido-Franco M, Richardson J, Nar H, Huber R, Bacher A: Zinc plays a key role in human and bacterial GTP cyclohydrolase I.  Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13567-72.</reference_text>
      <pubmed_id>11087827</pubmed_id>
    </reference>
    <reference>
      <reference_text>Ichinose H, Ohye T, Takahashi E, Seki N, Hori T, Segawa M, Nomura Y, Endo K, Tanaka H, Tsuji S, et al.: Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet. 1994 Nov;8(3):236-42.</reference_text>
      <pubmed_id>7874165</pubmed_id>
    </reference>
    <reference>
      <reference_text>Ichinose H, Ohye T, Segawa M, Nomura Y, Endo K, Tanaka H, Tsuji S, Fujita K, Nagatsu T: GTP cyclohydrolase I gene in hereditary progressive dystonia with marked diurnal fluctuation. Neurosci Lett. 1995 Aug 18;196(1-2):5-8.</reference_text>
      <pubmed_id>7501255</pubmed_id>
    </reference>
    <reference>
      <reference_text>Hirano M, Tamaru Y, Ito H, Matsumoto S, Imai T, Ueno S: Mutant GTP cyclohydrolase I mRNA levels contribute to dopa-responsive dystonia onset. Ann Neurol. 1996 Nov;40(5):796-8.</reference_text>
      <pubmed_id>8957022</pubmed_id>
    </reference>
    <reference>
      <reference_text>Bandmann O, Nygaard TG, Surtees R, Marsden CD, Wood NW, Harding AE: Dopa-responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneity. Hum Mol Genet. 1996 Mar;5(3):403-6.</reference_text>
      <pubmed_id>8852666</pubmed_id>
    </reference>
    <reference>
      <reference_text>Beyer K, Lao-Villadoniga JI, Vecino-Bilbao B, Cacabelos R, De la Fuente-Fernandez R: A novel point mutation in the GTP cyclohydrolase I gene in a Spanish family with hereditary progressive and dopa responsive dystonia. J Neurol Neurosurg Psychiatry. 1997 Apr;62(4):420-1.</reference_text>
      <pubmed_id>9120469</pubmed_id>
    </reference>
    <reference>
      <reference_text>Jarman PR, Bandmann O, Marsden CD, Wood NW: GTP cyclohydrolase I mutations in patients with dystonia responsive to anticholinergic drugs. J Neurol Neurosurg Psychiatry. 1997 Sep;63(3):304-8.</reference_text>
      <pubmed_id>9328244</pubmed_id>
    </reference>
    <reference>
      <reference_text>Furukawa Y, Kish SJ, Bebin EM, Jacobson RD, Fryburg JS, Wilson WG, Shimadzu M, Hyland K, Trugman JM: Dystonia with motor delay in compound heterozygotes for GTP-cyclohydrolase I gene mutations. Ann Neurol. 1998 Jul;44(1):10-6.</reference_text>
      <pubmed_id>9667588</pubmed_id>
    </reference>
    <reference>
      <reference_text>Bandmann O, Valente EM, Holmans P, Surtees RA, Walters JH, Wevers RA, Marsden CD, Wood NW: Dopa-responsive dystonia: a clinical and molecular genetic study.  Ann Neurol. 1998 Oct;44(4):649-56.</reference_text>
      <pubmed_id>9778264</pubmed_id>
    </reference>
    <reference>
      <reference_text>Hwu WL, Wang PJ, Hsiao KJ, Wang TR, Chiou YW, Lee YM: Dopa-responsive dystonia induced by a recessive GTP cyclohydrolase I mutation. Hum Genet. 1999 Sep;105(3):226-30.</reference_text>
      <pubmed_id>10987649</pubmed_id>
    </reference>
    <reference>
      <reference_text>Suzuki T, Ohye T, Inagaki H, Nagatsu T, Ichinose H: Characterization of wild-type and mutants of recombinant human GTP cyclohydrolase I: relationship to etiology of dopa-responsive dystonia. J Neurochem. 1999 Dec;73(6):2510-6.</reference_text>
      <pubmed_id>10582612</pubmed_id>
    </reference>
    <reference>
      <reference_text>Brique S, Destee A, Lambert JC, Mouroux V, Delacourte A, Amouyel P, Chartier-Harlin MC: A new GTP-cyclohydrolase I mutation in an unusual dopa-responsive dystonia, familial form. Neuroreport. 1999 Feb 25;10(3):487-91.</reference_text>
      <pubmed_id>10208576</pubmed_id>
    </reference>
    <reference>
      <reference_text>Hirano M, Komure O, Ueno S: A novel missense mutant inactivates GTP cyclohydrolase I in dopa-responsive dystonia. Neurosci Lett. 1999 Feb 5;260(3):181-4.</reference_text>
      <pubmed_id>10076897</pubmed_id>
    </reference>
    <reference>
      <reference_text>Tassin J, Durr A, Bonnet AM, Gil R, Vidailhet M, Lucking CB, Goas JY, Durif F, Abada M, Echenne B, Motte J, Lagueny A, Lacomblez L, Jedynak P, Bartholome B, Agid Y, Brice A: Levodopa-responsive dystonia. GTP cyclohydrolase I or parkin mutations?  Brain. 2000 Jun;123 ( Pt 6):1112-21.</reference_text>
      <pubmed_id>10825351</pubmed_id>
    </reference>
    <reference>
      <reference_text>Steinberger D, Korinthenberg R, Topka H, Berghauser M, Wedde R, Muller U: Dopa-responsive dystonia: mutation analysis of GCH1 and analysis of therapeutic doses of L-dopa. German Dystonia Study Group. Neurology. 2000 Dec 12;55(11):1735-7.</reference_text>
      <pubmed_id>11113234</pubmed_id>
    </reference>
    <reference>
      <reference_text>Leuzzi V, Carducci C, Carducci C, Cardona F, Artiola C, Antonozzi I: Autosomal dominant GTP-CH deficiency presenting as a dopa-responsive myoclonus-dystonia syndrome. Neurology. 2002 Oct 22;59(8):1241-3.</reference_text>
      <pubmed_id>12391354</pubmed_id>
    </reference>
    <reference>
      <reference_text>Ohta E, Funayama M, Ichinose H, Toyoshima I, Urano F, Matsuo M, Tomoko N, Yukihiko K, Yoshino S, Yokoyama H, Shimazu H, Maeda K, Hasegawa K, Obata F: Novel mutations in the guanosine triphosphate cyclohydrolase 1 gene associated with DYT5 dystonia. Arch Neurol. 2006 Nov;63(11):1605-10.</reference_text>
      <pubmed_id>17101830</pubmed_id>
    </reference>
  </general_references>
  <metabolite_references>
    <metabolite_reference>
      <metabolite>
        <name>Tetrahydrobiopterin</name>
        <accession>HMDB00027</accession>
      </metabolite>
      <reference>
        <reference_text>Auerbach G, Nar H: The pathway from GTP to tetrahydrobiopterin: three-dimensional structures of GTP cyclohydrolase I and 6-pyruvoyl tetrahydropterin synthase. Biol Chem. 1997 Mar-Apr;378(3-4):185-92.</reference_text>
        <pubmed_id>9165069</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Isopropyl alcohol</name>
        <accession>HMDB00863</accession>
      </metabolite>
      <reference>
        <reference_text>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there?  Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</reference_text>
        <pubmed_id>17139284</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Isopropyl alcohol</name>
        <accession>HMDB00863</accession>
      </metabolite>
      <reference>
        <reference_text>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets.  Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</reference_text>
        <pubmed_id>17016423</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Guanine</name>
        <accession>HMDB00132</accession>
      </metabolite>
      <reference>
        <reference_text>Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database.  Nucleic Acids Res. 2002 Jan 1;30(1):412-5.</reference_text>
        <pubmed_id>11752352</pubmed_id>
      </reference>
    </metabolite_reference>
  </metabolite_references>
</protein>
